Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00665353
What this trial is testing

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Who this might be right for
HIV-1 and Hepatitis C Co-Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 19
Not applicableActive Not RecruitingNCT04888754
What this trial is testing

A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands

Who this might be right for
HIV InfectionsHIV-1-infectionHIV-2 Infection
Erasmus Medical Center 35
Not applicableNot Yet RecruitingNCT07146529
What this trial is testing

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

Who this might be right for
HIV SeropositivityHIV Drug ResistanceHIV Infections
ANRS, Emerging Infectious Diseases 30,060
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00002324
What this trial is testing

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

Who this might be right for
HIV Infections
Boehringer Ingelheim 250
Not applicableStudy completedNCT01190124
What this trial is testing

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

Who this might be right for
HIV Infections
Doroana, Maria Manuela, M.D. 151
Post-approval studies (Phase 4)Ended earlyNCT01700790
What this trial is testing

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Who this might be right for
AIDSTuberculosis
University of Miami 9
Testing effectiveness (Phase 2)Study completedNCT00002079
What this trial is testing

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

Who this might be right for
HIV Infections
G D Searle
Testing effectiveness (Phase 2)Study completedNCT00299338
What this trial is testing

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

Who this might be right for
HIV Infections
Samaritan Pharmaceuticals, Inc 24
Testing effectiveness (Phase 2)Looking for participantsNCT04513626
What this trial is testing

HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label

Who this might be right for
HIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 150
Post-approval studies (Phase 4)Study completedNCT02042001
What this trial is testing

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

Who this might be right for
Impaired CognitionDepression/AnxietyPoor Quality Sleep+2 more
Azienda Ospedaliera San Gerardo di Monza 74
Early research (Phase 1)Study completedNCT00000777
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancyHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableUnknownNCT05243381
What this trial is testing

Inflammation, NK Cells, Antisense Protein and Exosomes, and Correlation With Immune Response During HIV Infection

Who this might be right for
HIV Infections
University Hospital, Montpellier 60
Testing effectiveness (Phase 2)Study completedNCT00122603
What this trial is testing

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 61
Early research (Phase 1)Study completedNCT01090648
What this trial is testing

TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients

Who this might be right for
HIV-Infections
Tibotec Pharmaceuticals, Ireland 49
Post-approval studies (Phase 4)UnknownNCT04222283
What this trial is testing

Switch to TAF+FTC+BIC in HIV-1-infected Patients Over 65 Years Old at Risk of Polymedication

Who this might be right for
HIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 27
Large-scale testing (Phase 3)UnknownNCT02219672
What this trial is testing

Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection

Who this might be right for
AIDS/HIV PROBLEM
Peking Union Medical College 18
Post-approval studies (Phase 4)WithdrawnNCT05295394
What this trial is testing

Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study

Who this might be right for
HIV-1 Infection
Pedro Cahn
Testing effectiveness (Phase 2)Study completedNCT00838162
What this trial is testing

Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

Who this might be right for
Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 33
Testing effectiveness (Phase 2)WithdrawnNCT00001094
What this trial is testing

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Next Page